Common use of EFFECTIVE DATE and PERIOD OF RESULTING PRICING AGREEMENT Clause in Contracts

EFFECTIVE DATE and PERIOD OF RESULTING PRICING AGREEMENT. The agreement will be effective upon signature of the Contracting Officer. However, prices will not be effective until loaded into the electronic pricing database by DLA upon receipt of the signed copy by the Contracting Officer. Prices will be loaded into the electronic pricing database by DLA on a date agreed to between the DLA and the Company; however, prices shall be effective in the DoD’s Prime Vendor systems for MTFs and TMOP purchases no later than 14 calendar days after the date this agreement is signed by the DHA Contracting Officer. However, the date that the formulary status changes and any restrictions are applied is the date the Director, DHA, makes the final UF decision or the effective date specified by the Director, DHA. The agreement will continue until 1) the drug class that contains this pharmaceutical agent(s) is/are reevaluated and any resulting changes implemented; or 2) it is otherwise terminated in accordance with Paragraph 8, Prices and Price Changes, or Paragraph 9, Termination, stated below. If the drug class containing this pharmaceutical agent(s) is/are reevaluated, this UF BPA, and the prices contained therein, will terminate when the prices in any follow-on UF BPA become effective, but no later than 14 calendar days after the follow-on UF BPA is signed.

EFFECTIVE DATE and PERIOD OF RESULTING PRICING AGREEMENT. The agreement will be effective upon signature of the Contracting Officer. However, prices will not be effective until loaded into the electronic pricing database by DLA upon receipt of the signed copy by the Contracting Officer. Prices will be loaded into the electronic pricing database by DLA on a date agreed to between the DLA and the Company; however, prices shall be effective in the DoD’s Prime Vendor systems for MTFs and TMOP purchases no later than 14 calendar days after the date this agreement is signed by the DHA Contracting Officer. However, the date that the formulary status changes and any restrictions are applied is the date the Director, DHA, makes the final UF decision or the effective date specified by the Director, DHA. The agreement will continue until 1) the drug class that contains this pharmaceutical agent(s) is/are reevaluated and any resulting changes implemented; or 2) it is otherwise terminated in accordance with Paragraph 8, Prices and Price Changes, or Paragraph 9Xxxxxxxxx 0, TerminationXxxxxxxxxxx, stated below. If the drug class containing this pharmaceutical agent(s) is/are reevaluated, this UF BPAUFBPA, and the prices contained therein, will terminate when the follow-on prices in any follow-on UF BPA UFBPA become effective, but no later than 14 calendar days after the follow-on UF BPA UFBPA is signed.